Camphor (Camphora)

Published December 5, 1984; Revised March 13, 1990.
List of German Commission E Monographs (Phytotherapy)


Name of Drug

Camphora, camphor.

Composition of Drug

Purified D (+) camphor obtained from the wood of the camphor tree, Cinnamomum camphora (L.) Siebold [Fam. Lauraceae], by steam distillation followed by sublimation, synthetic camphor or a mixture of both. It contains not less than 96 and not more than 101 percent 2-bornanone, of which at least 50 percent should be present as the (1R)-isomer.



Muscular rheumatism, catarrhal diseases of the respiratory tract, cardiac symptoms. Internal:

Hypotonic circulatory regulation disorders, catarrhal diseases of the respiratory tract. Contraindications External:

Injured skin, e.g., burns. Camphor preparations should not be used in the facial regions of infants and small children, especially in the nasal area.

Side Effects

Contact eczema possible.

Interactions with Other Drugs

None known.


Unless otherwise prescribed:


10 - 20 percent in semisolid preparations 1 - 10 percent in camphor spirits Internal:

Average daily dosage: 30 - 300 mg. Mode of Administration Locally or for inhalation:

in liquid or semi-solid form. Internal:

in liquid or solid preparations. Actions External:

Bronchial secretagogue Hyperemic Internal:

Circulatory tonic Respiratory analeptic Bronchoantispasmodic